Immunomedics

Former Immunomedics CFO pleads guilty to securities fraud over Trodelvy tip
Former Immunomedics CFO pleads guilty to securities fraud over Trodelvy tip
Fierce Biotech
Immunomedics
Usama Malik
insider trading
legal
Trodelvy
Flag link:
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Fierce Pharma
Gilead Sciences
Immunomedics
Trodelvy
Everest Medicines
Flag link:
Former Immunomedics CFO Usama Malik indicted for allegedly giving ex-girlfriend insider info
Former Immunomedics CFO Usama Malik indicted for allegedly giving ex-girlfriend insider info
Endpoints
Immunomedics
Usama Malik
legal
insider trading
securities fraud
Flag link:
Gilead's Immunomedics settles over-hyped ASCO data mishap for $4M
Gilead's Immunomedics settles over-hyped ASCO data mishap for $4M
Endpoints
Immunomedics
Gilead Sciences
ASCO
breast cancer
Flag link:
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
Fierce Pharma
Gilead Sciences
Immunomedics
Trodelvy
layoffs
Flag link:
Former biopharmaceutical executives nabbed for insider trading
Former biopharmaceutical executives nabbed for insider trading
Biopharma Reporter
DOJ
insider trading
Immunomedics
Usama Malik
Flag link:
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO
Fierce Biotech
SEC
insider trading
Immunomedics
Usama Malik
Flag link:
Quiet times return for biopharma takeouts
Quiet times return for biopharma takeouts
EP Vantage
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Flag link:
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
Astrazeneca shows megamergers were still possible in 2020
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Flag link:
The top 5 pharma M&A deals of 2020
The top 5 pharma M&A deals of 2020
Pharmaforum
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
Flag link:
Gilead rescues biopharma’s takeout scene
Gilead rescues biopharma’s takeout scene
EP Vantage
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
Flag link:
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst
Fierce Pharma
Gilead Sciences
Immunomedics
M&A
Trodelvy
ESMO
breast cancer
Flag link:
Esmo 2020 preview – late-breaking immunotherapy
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
ESMO
immunotherapy
Big Pharma
Merck
Bristol-Meyers Squibb
cancer
Immunomedics
Roche
Flag link:
Gilead to buy cancer drugmaker Immunomedics for $21B
Gilead to buy cancer drugmaker Immunomedics for $21B
BioPharma Dive
Gilead Sciences
M&A
cancer
Immunomedics
Flag link:
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Flag link:
Immunomedics Says Harout Semerjian Decided To Step Down From Role As President And CEO
Immunomedics Says Harout Semerjian Decided To Step Down From Role As President And CEO
Reuters
Immunomedics
Pharma CEOs
Harout Semerjian
Flag link:
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
Flag link:
FDA Approves Immunomedics' Breast Cancer Drug
FDA Approves Immunomedics' Breast Cancer Drug
Motley Fool
FDA
Immunomedics
triple negative breast cancer
Trodelvy
Flag link:
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Motley Fool
Clovis Oncology
Immunomedics
Puma Biotechnology
cancer
Flag link:

Pages